Patterns of discharge antiplatelet therapy and late outcomes among 8,582 patients with bleeding during acute coronary syndrome: A pooled analysis from PURSUIT, PARAGON-A, PARAGON-B, and SYNERGY

American Heart Journal

Volumn 160, Issue 6, 2010, Pages

  Chan, Mark Y ^a   Sun, Jie L ^c   Wang, Tracy Y ^c   Lopes, Renato D ^c   Jolicoeur, Marc E ^b,d   Pieper, Karen S ^c   Rao, Sunil V ^c,d   Newby, L Kristin ^c,d   Mahaffey, Kenneth W ^c,d   Harrington, Robert A ^c,d   Peterson, Eric D ^c,d  

^a NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^b MONTREAL HEART INSTITUTE   (Canada)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; THIENOPYRIDINE DERIVATIVE;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STENT; STROKE; TREATMENT OUTCOME;

EID: 78650223707     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.09.001     Document Type: Article

References (24)

1. Rao S.V., O'Grady K., and Pieper K.S. A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes J Am Coll Cardiol 47 2006 809 816
2. Berger J.S., Frye C.B., and Harshaw Q. Impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery: a multicenter analysis J Am Coll Cardiol 52 2008 1693 1701
3. Subherwal S., Bach R.G., and Chen A.Y. Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding Score Circulation 119 2009 1873 1882
4. Eikelboom J.W., Mehta S.R., and Anand S.S. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes Circulation 114 2006 774 782
5. Moscucci M., Fox K.A., and Cannon C.P. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE) Eur Heart J 24 2003 1815 1823
6. Mehran R., Pocock S.J., and Stone G.W. Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial Eur Heart J 30 2009 1457 1466
7. Doyle B.J., Rihal C.S., and Gastineau D.A. Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: implications for contemporary practice J Am Coll Cardiol 53 2009 2019 2027
8. Wang T.Y., Xiao L., and Alexander K.P. Antiplatelet therapy use after discharge among acute myocardial infarction patients with in-hospital bleeding Circulation 118 2008 2139 2145
9. The PARAGON Investigators International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina. Platelet IIb/IIIa Antagonism for the Reduction of Acute coronary syndrome events in a Global Organization Network Circulation 97 1998 2386 2395
10. The PARAGON Investigators Randomized, placebo-controlled trial of titrated intravenous lamifiban for acute coronary syndromes Circulation 105 2002 316 321
11. Ferguson J.J., Califf R.M., and Antman E.M. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial JAMA 292 2004 45 54
12. The PURSUIT Trial Investigators Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy N Engl J Med 339 1998 436 443
13. The SYNERGY trial: study design and rationale Am Heart J 143 2002 952 960
14. Chan M.Y., Mahaffey K.W., and Sun L.J. Prevalence, predictors, and impact of conservative medical management for patients with non-ST-segment elevation acute coronary syndromes who have angiographically documented significant coronary disease JACC CI 1 2008 369 378
15. Lin J., Zhang D., and Davidian M. Smoothing spline-based score tests for proportional hazards models Biometrics 62 2006 803 812
16. Chan M.Y., Sun J.L., and Newby L.K. Long-term mortality of patients undergoing cardiac catheterization for ST-elevation and non-ST-elevation myocardial infarction Circulation 119 2009 3110 3117
17. Rao S.V., Jollis J.G., and Harrington R.A. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes JAMA 292 2004 1555 1562
18. Spencer F.A., Moscucci M., and Granger C.B. Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction? Circulation 116 2007 2793 2801
19. Jolicoeur E.M., O'Neill W.W., and Hellkamp A. Transfusion and mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention Eur Heart J 30 2009 2575 2583
20. Bassand J.P., Hamm C.W., and Ardissino D. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes Eur Heart J 28 2007 1598 1660
21. Anderson J.L., Adams C.D., and Antman E.M. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine J Am Coll Cardiol 50 2007 e1 e157
22. Mehta S.R., Yusuf S., and Peters R.J. The PCI-CURE study Lancet 358 2001 527 533
23. Yusuf S., Zhao F., and Mehta S.R. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502
24. Unger E.F. Weighing benefits and risks-the FDA's review of prasugrel N Engl J Med 361 2009 942 945